📚 PsyDin Research Database

← PsyDin Home
Showing 15 of 20167 papers

JAVEMACS: a real-world study of avelumab maintenance therapy for advanced urothelial carcinoma in Japan.

Authors: Kitamura H, Kobayashi T, Endo Y, Ikeda M, Yonemori K, Nakayama M, Fujihara A, Abe T, Shimizu F, Fujimoto K, Nakagawa T, Hatakeyama S, Murakami K, Nishihara K, Ikarashi D, Masumori N, Naito S, Fujita K, Hayakawa N, Hara T, Miura N, Negishi T, Yatsuda J, Kobayashi M, Nishiyama N, Taoka R, Furukawa J, Shono M, Shirotake S, Kikuchi E

ESMO real world data and digital oncology

acceptance commitment therapy mental health open access

Non-redundant functions of NFATc1 in survival and NFATc2 in generation of exhausted CD8(+) T cells.

Authors: Sampere-Birlanga S, Klein-Hessling S, Campillo Prados M, Huang A, Wu H, Rosenwald A, Kastenmüller W, Serfling E, Vaeth M, Berberich-Siebelt F

Frontiers in immunology

acceptance commitment therapy mental health open access

Mechanisms and management strategies for exacerbated bone loss following denosumab discontinuation.

Authors: Yang J, Yang M, Zeng Y

Frontiers in aging

acceptance commitment therapy mental health open access

From neuraminidase inhibitors to novel mechanisms: expanding therapeutic strategies against influenza.

Authors: Sun Y, Kunanusorn P, Tup KM, Chokkakula S, Yang B

Frontiers in cellular and infection microbiology

acceptance commitment therapy mental health open access

Traditional Chinese medicine-induced cardiac adverse reactions: a critical review of current evidence, knowledge gaps, and pharmacovigilance strategies.

Authors: Cai X, Yasien K, Gan R, Zhou Q, Zhang B, Wang Y, Zhang X, Lin Z

Frontiers in pharmacology

acceptance commitment therapy mental health open access

Conserved CD4 T-cell responses correlate with antibody neutralization in solid organ transplant recipients after bivalent SARS-CoV-2 vaccination.

Authors: Stavrakis G, Roznik K, Stoddart L, Johnston TS, Panda S, Hage C, Teles AT, Eby Y, Werbel WA, Tobian AAR, Milstone AM, Sette A, Grifoni A, Karaba AH, Thompson EA, Cox AL

Frontiers in immunology

acceptance commitment therapy mental health open access

Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells.

Authors: Watanabe R, Chosei M, Arai H, Miura N, Kikugawa T, Saika T

Frontiers in oncology

acceptance commitment therapy mental health open access

The Divide-Survive Matrix: decoupling proliferative drive from intrinsic survival architecture in oncology.

Authors: Heavenor GM

Frontiers in oncology

acceptance commitment therapy mental health open access

Catalysing tuberculosis elimination in Indonesia: Health economic and policy insights from the BPaL regimen.

Authors: Antaria A, Agustina H, Ratnawati R, Andarini SL, Handayani D

PloS one

acceptance commitment therapy mental health open access

EZ-SPOTs: a simple, low-cost, high-throughput liquid handling platform applied to antimicrobial susceptibility testing of clinical isolates.

Authors: Albo J, Tan S, Denis JD, Franklin-Guild R, Shiri S, Sandoz KM, Cira NJ

Lab on a chip

acceptance commitment therapy mental health open access

Evaluation of a Minigrant Program for Multilevel Interventions to Promote Human Papillomavirus Vaccination in Rural Communities in Georgia.

Authors: Escoffery C, Petagna C, Chari R, Hsu E, Kadoo RV, Haardörfer R, Guan Y, Morshed AB, Wells J, Blake S, Hutchins R

Preventing chronic disease

acceptance commitment therapy mental health open access

Sex-stratified mortality trends in preterm birth complications in Sierra Leone: progress, persistence, and equity implications.

Authors: Bai-Sesay AU, Jones RD, Baun APS, Sesay DKD

Global health action

acceptance commitment therapy mental health open access

Heterologous prime-boost vaccination against H5 avian influenza: Safety and immunogenicity of a MF59-adjuvanted, cell-culture derived H5N6 vaccine.

Authors: Van Twuijver E, Versage E, Jacobs RL, Hohenboken M

Human vaccines & immunotherapeutics

acceptance commitment therapy mental health open access

Phase 1/2 study of INCAGN01876, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, plus immunotherapy for advanced cancers.

Authors: Hamid O, Forget F, Johnson M, George TJ, Bourayou N, Ioannidis S, Zhou F, Yang H, Dong Z, Gutierrez ME

The oncologist

acceptance commitment therapy mental health open access